Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sterling Pharma Solutions, has announced that its customer, ADC Therapeutics SA, has received FDA approval for the antibody drug conjugate ZYNLONTATM that its Deeside facility contributed to developing.
read more
Thursday, December 17, 2015
Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals have announced that the U.S. Food and Drug Administration (FDA) granted approval for Basaglar® (insulin glargine injection) 100 units/mL.
read more
Wednesday, April 13, 2022
Biofrontera Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Biofrontera Pharma’s cGMP laboratory in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz® (aminolevulinic acid ...
read more
Wednesday, February 18, 2026
Rezon Bio announced that its Warsaw-Duchnice facility has received approval from the FDA for the commercial manufacturing of a biosimilar.
read more
Wednesday, November 11, 2015
The U.S. Food and Drug Administration has approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can’t be removed by surgery, and that has a certain type of ...
read more
Wednesday, February 03, 2016
Dr. Reddy's Laboratories has announced that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with ...
read more
Friday, November 20, 2015
The U.S. Food and Drug Administration has approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose.
read more
Tuesday, October 06, 2020
Ajinomoto Bio-Pharma Services announced the FDA has approved the first commercial drug manufactured using the company's AJIPHASE production process.
read more
Wednesday, April 08, 2020
The FDA approved the first generic of Proventil HFA Metered Dose Inhaler, 90 mcg/Inhalation, for treatment or prevention of bronchospasm.
read more
Wednesday, August 12, 2020
The FDA approved the first liquid biopsy companion diagnostic that also uses NGS technology to identify patients with specific types of mutations of the EGFR gene.
read more
Wednesday, August 19, 2015
The FDA has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.
read more
Thursday, December 17, 2020
GBT has received FDA approval for the commercial sale of the Optiray® Imaging Bulk Package in the United States.
read more
Wednesday, February 17, 2016
Impax Laboratories has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine ...
read more
Wednesday, April 06, 2016
The U.S. Food and Drug Administration has approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA.
read more
Janssen Pharmaceuticals has announced that the FDA approved under priority review the New Drug Application (NDA) for the three-month long-acting atypical antipsychotic INVEGA TRINZA™.
read more